Erica Liu, MD
Ophthalmology · Torrance, CANPI 1528402633
Payments from drug & device makers
Across 116 payments — averaging $322.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$27K
- Carl Zeiss Meditec USA, Inc.$8K
- Alcon$717
- Johnson & Johnson Surgical Vision, Inc.$292
- Bausch & Lomb Americas Inc.$204
- AbbVie$191
- plus $874 from 10 others
What the payments were for
- Consulting fees$7,94028%
- Speaking & faculty fees$15,03054%
- Travel & lodging$9123%
- Food & beverage$4,09015%
- Education$50%
- Gifts$860%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 28 | $27,079 |
| Carl Zeiss Meditec USA, Inc. | 30 | $8,061 |
| Alcon | 16 | $717 |
| Johnson & Johnson Surgical Vision, Inc. | 8 | $292 |
| Bausch & Lomb Americas Inc. | 2 | $204 |
| AbbVie | 2 | $191 |
| Tarsus Pharmaceuticals, Inc. | 5 | $176 |
| Shire North American Group Inc | 9 | $172 |
| Harrow Eye, LLC | 3 | $147 |
| Janssen Scientific Affairs, LLC | 1 | $114 |
| Rxsight Inc | 4 | $86 |
| Biotissue Holdings Inc. | 2 | $49 |
| Sight Sciences, Inc. | 1 | $38 |
| Beaver-visitec International, Inc. | 2 | $36 |
| Sun Pharmaceutical Industries Inc. | 2 | $36 |
| Glaukos Corporation | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VisuMax$20,905
- MEL 90$4,790
- QUATERA 700$1,875
- FORUM$1,675
- VERACITY SURGICAL$1,380
- Cataract Suite$1,125
- CIRRUS HD-OCT$1,005
- IOLMaster 700$805
- CALLISTO eye$750
- CIRRUS 6000 with AngioPlex$750
- FORUM Glaucoma Workplace$550
- Humphrey HFA$550
- ARTEVO 800$255
- EQ Workplace$190
- VEVYE$125
- Clareon$121
- enVista MX60 IOL$120
- AMVISC$120
- Tremfya$114
- AcrySof IQ VIVITY IOL$111
How this compares
$37,419 in reported general payments places this provider in the 85th percentile of 2,513 ophthalmology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 25 | $786 |
| Latanoprost | 34 | $291 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 13 | $227 |
| Timolol Maleate | 19 | $212 |
| ErythromycinErythromycin Base | 18 | $147 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Torrance
- Damien GoldbergTorrance$4.1M
- Mehran TabanTorrance$893K
- Nisha AcharyaSan Francisco$33M
- David WirtaNewport Beach$18.4M
- Michael IpPasadena$10.2M
- Raymond DouglasBeverly Hills$9.7M
- Sherif El HaraziGlendale$9.2M
- Daniel SchwartzSan Francisco$8M
- Nikolas Londonla Jolla$6.1M
- Michael BerlinWest Hollywood$5.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.